what is in glp-1 GLP-1 Medications for Weight Loss:

A study conducted on 76 patients with advanced CKD (stage 4 or higher) who began semaglutide treatment between January 2018 and January 2023 revealed that many safely reached therapeutic doses

18 Because manufacturers new patents and regulatory exclusivities can emerge over time, we extracted data on patent and regulatory exclusivity listings in every annual edition of the Orange Book from the year following the drugs approval until 2022

doi: 10.1111/j.1476-5381.1947.tb00336.x

Flexible titration schedules and ongoing support programs can make a big difference in managing side effects while achieving sustainable weight loss

Clinician-guided titration, routine monitoring, and patient education help mitigate risk, and ongoing research continues to refine duration-of-therapy recommendations to balance sustained benefit and safety

Many patients can successfully manage hair loss while continuing their medication by optimizing nutrition, slowing the rate of weight loss through dose adjustment, and adding hair-supportive treatments